Wolverine (BPC-157 + TB-500) 20 mg is a dual-peptide research formulation combining BPC-157 and TB-500 (Thymosin Beta-4 fragment, TB4-400 / 43aa) into a single lyophilized vial. This consolidated format replaces the prior two-vial presentation while preserving the same total peptide content—10 mg BPC-157 and 10 mg TB-500, for a combined 20 mg.

BPC-157 is a gastric-derived pentadecapeptide fragment that has been widely investigated in preclinical research for its role in tissue protection, angiogenic signaling, microvascular integrity, and inflammatory pathway modulation. Studies frequently examine its influence on nitric-oxide signaling, epithelial stability, and cytokine balance across a range of experimental models.

TB-500 (Thymosin Beta-4 fragment) is a synthetic peptide corresponding to the active region of the naturally occurring actin-binding protein thymosin beta-4. In research settings, TB-500 is evaluated for its involvement in cellular migration, cytoskeletal organization, and extracellular-matrix remodeling, particularly in models focused on tissue repair and regeneration dynamics.

When combined in a single formulation, BPC-157 and TB-500 present complementary mechanisms of interest: BPC-157 contributing to vascular stability and inflammatory modulation, and TB-500 supporting actin-mediated cell motility and structural reorganization. This pairing is frequently explored in preclinical studies to assess potential additive or synergistic effects on coordinated tissue-repair processes.

Current areas of research interest for the BPC-157 + TB-500 combination include:

• Musculoskeletal and connective-tissue research, including experimental models of muscle, tendon, and ligament repair
• Angiogenesis and microvascular studies, particularly where enhanced vascular support may influence recovery dynamics
• Cytoskeletal and cellular-migration investigations involving fibroblast and endothelial cell behavior
• Inflammatory-response modulation, with attention to cytokine signaling and tissue-stress pathways
• Wound-healing and tissue-regeneration models examining extracellular-matrix organization and structural remodeling

This single-vial Wolverine formulation is produced to 99% purity as verified by HPLC analysis and is intended exclusively for laboratory and research use.
Not for human or veterinary use.